Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02992340
Status:
TERMINATED
Last Update Posted:
2021-01-14
First Post:
2016-12-08
Brief Title:
Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
Sponsor:
ASLAN Pharmaceuticals
Organization:
ASLAN Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Biliary Tract Cancer |
Keywords: